ACAT1-associated Late Endosomes/Lysosomes Significantly Improve Impaired Intracellular Cholesterol Metabolism and the Survival of Niemann-Pick Type C Mice

Access this Article

Search this Article

Author(s)

    • Kamikawa Masashi
    • Department of Cell Pathology, Graduate School of Medical Sciences, Kumamoto University|Department of Orthopaedic Surgery, Graduate School of Medical Sciences, Kumamoto University
    • Lei XiaoFeng
    • Department of Biochemistry, Showa University School of Medicine
    • Fujiwara Yukio
    • Department of Cell Pathology, Graduate School of Medical Sciences, Kumamoto University
    • Nishitsuji Kazuchika
    • Department of Human Pathology, Institute of Health Biosciences, The University of Tokushima Graduate School
    • Mizuta Hiroshi
    • Department of Orthopaedic Surgery, Graduate School of Medical Sciences, Kumamoto University
    • Takeya Motohiro
    • Department of Cell Pathology, Graduate School of Medical Sciences, Kumamoto University
    • Sakashita Naomi
    • Department of Cell Pathology, Graduate School of Medical Sciences, Kumamoto University|Department of Human Pathology, Institute of Health Biosciences, The University of Tokushima Graduate School

Abstract

We previously demonstrated that macrophages exhibit endoplasmic reticulum fragmentation under cholesterol-rich conditions, which results in the generation of acyl-coenzyme A: cholesterol acyltransferase 1 (ACAT1)-associated late endosomes/lysosomes (ACAT1-LE). ACAT1-LE efficiently esterify free cholesterol <i>in loco</i>, even with abnormal egress of free cholesterol from late endosomes. Because impaired free cholesterol transport from late endosomes results in Niemann-Pick type C disease (NPC), the induction of ACAT1-LE is a potential therapeutic intervention for NPC. To examine the effects of ACAT1-LE induction on intracellular cholesterol metabolism, we incubated bone marrow-derived macrophages possessing NPC phenotype (<i>npc1</i><sup>–/–</sup>) with methyl-β-cyclodextrin-cholesterol complex (mβCD-cho), a cholesterol donor. Immunofluorescence confocal microscopy revealed that mβCD-cho treatment of <i>npc1</i><sup>–/–</sup> macrophages resulted in significant colocalization of signals from ACAT1 and lysosome-associated membrane protein 2, a late endosome/lysosome marker. <i>npc1</i><sup>–/–</sup> macrophages contained significant amounts of free cholesterol with negligible amounts of cholesteryl ester, while wild-type macrophages possessed the same amounts of both cholesterols. mβCD-cho treatment also induced marked restoration of cholesterol esterification activity. mβCD-cho administration in neonate <i>npc1</i><sup>–/–</sup> mice improved survival. These results indicate that ACAT1-LE induction in <i>npc1</i><sup>–/–</sup> mice corrects impaired intracellular cholesterol metabolism and that restoring cholesterol esterification improves prognosis of <i>npc1</i><sup>–/–</sup>. These data suggest that ACAT1-LE induction is a potential alternative therapeutic strategy for NPC.

Journal

  • ACTA HISTOCHEMICA ET CYTOCHEMICA

    ACTA HISTOCHEMICA ET CYTOCHEMICA 47(2), 35-43, 2014

    JAPAN SOCIETY OF HISTOCHEMISTRY AND CYTOCHEMISTRY

Codes

  • NII Article ID (NAID)
    130003390848
  • Text Lang
    ENG
  • ISSN
    0044-5991
  • Data Source
    J-STAGE 
Page Top